How do you identify high risk patients who are likely to benefit from biological therapy?

How do you identify high risk patients who are likely to benefit from biological therapy?

How do you identify high risk patients who are likely to benefit from biological therapy?

CLICK HERE FOR CME CREDIT

Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Richard M. Pope, MD

Richard M. Pope, MD

Mabel Green Myers Professor of Medicine
Chief, Division of Rheumatology
Northwestern University Medical School
Chicago, IL